NCT03525847View on ClinicalTrials.gov

The Added Value of Contrast Enhancement for Guiding EUS-FNA in Solid Pancreatic Masses

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

January 1, 2019

Study Completion Date

January 1, 2020

Conditions
Endoscopic Ultrasonography
Interventions
DIAGNOSTIC_TEST

Endosonography

Puncture of the pancreatic solid mass with fine needle aspiration under endoscopic ultrasonographic control. Passage in the same pancreatic mass of first using standard FNA method then contrast enhanced FNA method or vice versa according to the randomization

Trial Locations (1)

Unknown

Seicean Andrada, Cluj-Napoca

All Listed Sponsors
lead

Professor Dr. Seicean Andrada

OTHER

NCT03525847 - The Added Value of Contrast Enhancement for Guiding EUS-FNA in Solid Pancreatic Masses | Biotech Hunter | Biotech Hunter